TY - JOUR
T1 - Esmo consensus conferences
T2 - Guidelines on malignant lymphoma. Part 2: Marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
AU - Dreyling, M.
AU - Thieblemont, C.
AU - Gallamini, A.
AU - Arcaini, L.
AU - Campo, E.
AU - Hermine, O.
AU - Kluin-Nelemans, J. C.
AU - Ladetto, M.
AU - Le Gouill, S.
AU - Iannitto, E.
AU - Pileri, S.
AU - Rodriguez, J.
AU - Schmitz, N.
AU - Wotherspoon, A.
AU - Zinzani, P.
AU - Zucca, E.
PY - 2013/4
Y1 - 2013/4
N2 - To complement the existing treatment guidelines for all tumour types, ESMO organizes consensus conferences to focus on specific issues in each type of tumour. In this setting, a consensus conference on the management of lymphoma was held on 18 June 2011 in Lugano, next to the 11th International Conference on Malignant Lymphoma. The conference convened {ogonek}30 experts from all around Europe, and selected six lymphoma entities to be addressed; for each of them, three to five open questions were to be addressed by the experts. For each question, a recommendation should be given by the panel, referring to the strength of the recommendation based on the level of evidence. This consensus report focuses on the three less common lymphoproliferative malignancies: marginal zone lymphoma, mantle cell lymphoma, and peripheral T-cell lymphomas. A first report had focused on diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukaemia.
AB - To complement the existing treatment guidelines for all tumour types, ESMO organizes consensus conferences to focus on specific issues in each type of tumour. In this setting, a consensus conference on the management of lymphoma was held on 18 June 2011 in Lugano, next to the 11th International Conference on Malignant Lymphoma. The conference convened {ogonek}30 experts from all around Europe, and selected six lymphoma entities to be addressed; for each of them, three to five open questions were to be addressed by the experts. For each question, a recommendation should be given by the panel, referring to the strength of the recommendation based on the level of evidence. This consensus report focuses on the three less common lymphoproliferative malignancies: marginal zone lymphoma, mantle cell lymphoma, and peripheral T-cell lymphomas. A first report had focused on diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukaemia.
KW - Malignant lymphoma guidelines
KW - Mantle cell lymphoma
KW - Marginal zone lymphoma
KW - T-cell lymphoma
UR - http://www.scopus.com/inward/record.url?scp=84875594520&partnerID=8YFLogxK
U2 - 10.1093/annonc/mds643
DO - 10.1093/annonc/mds643
M3 - Article
SN - 0923-7534
VL - 24
SP - 857
EP - 877
JO - Annals of Oncology
JF - Annals of Oncology
IS - 4
ER -